Your browser doesn't support javascript.
loading
Identification of triazenyl indoles as inhibitors of fungal fatty acid biosynthesis with broad-spectrum activity.
Iyer, Kali R; Li, Sheena C; Revie, Nicole M; Lou, Jennifer W; Duncan, Dustin; Fallah, Sara; Sanchez, Hiram; Skulska, Iwona; Usaj, Mojca Mattiazzi; Safizadeh, Hamid; Larsen, Brett; Wong, Cassandra; Aman, Ahmed; Kiyota, Taira; Yoshimura, Mami; Kimura, Hiromi; Hirano, Hiroyuki; Yoshida, Minoru; Osada, Hiroyuki; Gingras, Anne-Claude; Andes, David R; Shapiro, Rebecca S; Robbins, Nicole; Mazhab-Jafari, Mohammad T; Whitesell, Luke; Yashiroda, Yoko; Boone, Charles; Cowen, Leah E.
Afiliação
  • Iyer KR; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Li SC; Donnelly Centre for Cellular & Biomolecular Research, University of Toronto, Toronto, ON, Canada; RIKEN Center for Sustainable Resource Science, Wako, Japan.
  • Revie NM; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Lou JW; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
  • Duncan D; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Fallah S; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Sanchez H; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA; Department of Medical Microbiology and Immunology, University of Wisconsin, Madison, WI, USA.
  • Skulska I; Department of Molecular and Cellular Biology, University of Guelph, Guelph, ON, Canada.
  • Usaj MM; Department of Chemistry and Biology, Toronto Metropolitan University, Toronto, ON, Canada.
  • Safizadeh H; Department of Computer Science and Engineering and Department of Electrical and Computer Engineering, University of Minnesota-Twin Cities, Minneapolis, MN, USA.
  • Larsen B; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada; Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, ON, Canada.
  • Wong C; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada; Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, ON, Canada.
  • Aman A; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, ON, Canada; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.
  • Kiyota T; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Yoshimura M; RIKEN Center for Sustainable Resource Science, Wako, Japan.
  • Kimura H; RIKEN Center for Sustainable Resource Science, Wako, Japan.
  • Hirano H; RIKEN Center for Sustainable Resource Science, Wako, Japan.
  • Yoshida M; RIKEN Center for Sustainable Resource Science, Wako, Japan.
  • Osada H; RIKEN Center for Sustainable Resource Science, Wako, Japan.
  • Gingras AC; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada; Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, ON, Canada.
  • Andes DR; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA; Department of Medical Microbiology and Immunology, University of Wisconsin, Madison, WI, USA.
  • Shapiro RS; Department of Molecular and Cellular Biology, University of Guelph, Guelph, ON, Canada.
  • Robbins N; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Mazhab-Jafari MT; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada.
  • Whitesell L; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Yashiroda Y; RIKEN Center for Sustainable Resource Science, Wako, Japan. Electronic address: ytyy@riken.jp.
  • Boone C; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada; Donnelly Centre for Cellular & Biomolecular Research, University of Toronto, Toronto, ON, Canada; RIKEN Center for Sustainable Resource Science, Wako, Japan. Electronic address: charlie.boone@utoronto.ca.
  • Cowen LE; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada. Electronic address: leah.cowen@utoronto.ca.
Cell Chem Biol ; 30(7): 795-810.e8, 2023 07 20.
Article em En | MEDLINE | ID: mdl-37369212
Rising drug resistance among pathogenic fungi, paired with a limited antifungal arsenal, poses an increasing threat to human health. To identify antifungal compounds, we screened the RIKEN natural product depository against representative isolates of four major human fungal pathogens. This screen identified NPD6433, a triazenyl indole with broad-spectrum activity against all screening strains, as well as the filamentous mold Aspergillus fumigatus. Mechanistic studies indicated that NPD6433 targets the enoyl reductase domain of fatty acid synthase 1 (Fas1), covalently inhibiting its flavin mononucleotide-dependent NADPH-oxidation activity and arresting essential fatty acid biosynthesis. Robust Fas1 inhibition kills Candida albicans, while sublethal inhibition impairs diverse virulence traits. At well-tolerated exposures, NPD6433 extended the lifespan of nematodes infected with azole-resistant C. albicans. Overall, identification of NPD6433 provides a tool with which to explore lipid homeostasis as a therapeutic target in pathogenic fungi and reveals a mechanism by which Fas1 function can be inhibited.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Candida albicans / Antifúngicos Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Candida albicans / Antifúngicos Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article